Device: propofol dosage (DrugBank: Propofol)
1 disease| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 84 | サルコイドーシス | 1 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02246023 (ClinicalTrials.gov) | January 2015 | 15/9/2014 | Fractionated Versus Target-controlled Propofol Administration in Bronchoscopy | Target-controlled Versus Manually-controlled Propofol Sedation in Flexible Bronchoscopy. A Randomized Non-inferiority Trial. | Lung Cancer;Sarcoidosis;Interstitial Pneumonia | Device: Flexible bronchoscopy in moderate sedation;Device: Oxygen saturation;Device: Blood pressure;Device: Propofol dosage;Device: Recovery time after bronchoscopy | Daniel Franzen | B. Braun Melsungen AG | Completed | 18 Years | 85 Years | Both | 78 | Phase 4 | Switzerland |